Are you Dr. Kearney?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8950 Villa La Jolla Dr
Ste C217
La Jolla, CA 92037Phone+1 858-869-8699Fax+1 858-638-8142
Summary
- Dr. Jennifer Kearney, MD is a board certified psychiatrist in La Jolla, California. She is currently licensed to practice medicine in California and New Jersey.
Education & Training
- Georgetown University School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 2016 - 2025
- NJ State Medical License 1996 - 2017
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- 122 citationsStrain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome miceAkshitkumar M. Mistry, Christopher H. Thompson, Alison R. Miller, Carlos G. Vanoye, Alfred L. George
Neurobiology of Disease. 2014-05-01 - 66 citationsNovel SCN3A variants associated with focal epilepsy in children.Carlos G. Vanoye, Christina A. Gurnett, Katherine D. Holland, Alfred L. George, Jennifer A. Kearney
Neurobiology of Disease. 2014-02-01 - 57 citationsVoltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibilityBenjamin S. Jorge, Courtney M. Campbell, Alison R. Miller, Elizabeth D. Rutter, Christina A. Gurnett
Proceedings of the National Academy of Sciences of the United States of America. 2011-03-29
Press Mentions
- 'Mother of All Cannabinoids': Anti-Seizure Compounds Found in CannabisOctober 5th, 2021
- Boston Researchers Using COVID-19 Patients’ DNA to Unlock Secrets About Impact of VirusJune 11th, 2020
- Versius®: A New Paradigm in Robotic Assisted SurgeryMay 1st, 2020
Grant Support
- Genetic Mapping of Modifier Loci in a Mouse Model KCNB1 EncephalopathyNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- Genetic Mapping of Modifier Loci in a Mouse Model KCNB1 EncephalopathyNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskIMMUNOCHEM THERAPEUTICS, LLC2021–2025
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskIMMUNOCHEM THERAPEUTICS, LLC2021–2025
- Genetic Modifiers of Childhood EpilepsyNORTHWESTERN UNIVERSITY AT CHICAGO2014–2025